Antimicrobial Susceptibility Testing Market to Grow with a CAGR of 5.17% through 2030
The rise in
healthcare-associated infections and the continuous advancements in
antimicrobial susceptibility testing technologies, is expected to drive the
Global Antimicrobial Susceptibility Testing Market growth in the forecast
period, 2026-2030
According to
TechSci Research report, “Antimicrobial Susceptibility Testing Market –
Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030F”, the Global Antimicrobial Susceptibility Testing
Market stood at USD 4.41
Billion in 2024 and is expected to reach USD 5.98 Billion by
2030 with a CAGR of 5.17% during the forecast period. The Global Antimicrobial Susceptibility
Testing (AST) Market is poised for growth due to the increasing global burden
of infectious diseases and the rise of antimicrobial resistance (AMR). The
growing number of hospital-acquired infections (HAIs) and the shift towards
precision medicine are significant factors pushing the demand for effective AST
tools. As the limitations of broad-spectrum antibiotics become evident, the
need for targeted therapies, guided by AST results, has never been more
critical. The push for faster diagnostic solutions that can provide quick and
accurate results is a key driver, as healthcare providers seek to minimize
delays in administering the correct treatments. Moreover, the development of
more sophisticated and automated systems is enabling rapid AST processes,
making it more feasible to integrate into clinical workflows.
A
significant market trend is the increasing adoption of molecular diagnostics,
which offer the advantage of delivering results in a shorter timeframe compared
to traditional culture-based methods. The growing preference for point-of-care
(POC) testing is also shaping the market landscape, as these devices allow for
quick antimicrobial susceptibility results without the need for centralized
laboratories. As hospitals and diagnostic centers face pressure to reduce the
time from diagnosis to treatment, automated AST technologies that streamline
workflows and enhance efficiency are becoming integral in modern healthcare
settings. The integration of digital health technologies, such as AI-based
systems that can predict bacterial resistance patterns, further accelerates the
adoption of AST methods.
As
the global focus on combating antimicrobial resistance intensifies, there are
numerous growth opportunities for the AST market. Companies are focusing on the
development of cost-effective, user-friendly testing solutions that can be
implemented in resource-constrained environments. Expanding the reach of AST
technology in emerging markets through strategic partnerships and
collaborations can unlock new growth avenues. With increasing government and
healthcare investments in diagnostic technologies, especially in regions where
infectious diseases are prevalent, the market stands to benefit from expanding
accessibility to rapid AST systems. Furthermore, as research continues into
personalized medicine, AST is expected to play a pivotal role in enabling tailored
antibiotic treatments, further driving market growth.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Antimicrobial Susceptibility Testing Market”
The Global Antimicrobial
Susceptibility Testing Market is segmented into product, technique, application,
end user, regional distribution, and company.
Based on the Application,
Drug Development emerged as the fastest growing segment in the Global Antimicrobial
Susceptibility Testing Market during the forecast period. This is due to the
increasing need for more effective antibiotics and treatments for
antimicrobial-resistant infections. As resistance to existing drugs continues
to rise, pharmaceutical companies are focused on developing new antimicrobial
agents, which requires comprehensive and accurate testing of bacterial
susceptibility. AST plays a critical role in identifying the most effective
drugs for specific pathogens during clinical trials, ensuring that novel
treatments can target resistant strains effectively. The surge in
drug-resistant infections worldwide has amplified the urgency for the
development of new antibiotics, further increasing the demand for AST in drug
development processes. The use of advanced AST techniques, such as automated
systems and molecular diagnostics, helps pharmaceutical companies speed up the
process of identifying resistant strains, reducing development timelines.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Antimicrobial Susceptibility Testing Market during the forecast period. The rapid expansion of the
Asia-Pacific market can also be attributed to the increasing burden of
infectious diseases and a high prevalence of multi-drug-resistant pathogens.
Countries in the region are facing growing challenges in controlling infections,
especially due to the high population density, limited healthcare resources in
some areas, and evolving patterns of resistance to antibiotics. This has
heightened the need for more precise and rapid susceptibility testing methods.
With improving access to modern healthcare technologies, Asia-Pacific is seeing
a higher uptake of automated AST systems, molecular diagnostic platforms, and
other innovative solutions that can provide faster, more accurate results. As
the region continues to urbanize and healthcare access improves, the demand for
advanced antimicrobial testing methods is expected to accelerate, making
Asia-Pacific the fastest-growing market for AST solutions.
Major
companies operating in Global Antimicrobial Susceptibility Testing Market
are:
- Bio-Rad
Laboratories Inc.
- Merck
& Co., Inc.
- Thermo
Fisher Scientific Inc.
- Danaher
Corporation
- bioMérieux
SA
- Becton,
Dickinson and Company
- ELITech
Group SAS
- F.
Hoffmann-La Roche Ltd.
- Accelerate
Diagnostics, Inc.
- HiMedia
Laboratories Private Limited
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Antimicrobial Susceptibility
Testing Market is expanding due to the increasing emphasis on combating
antimicrobial resistance (AMR) and the growing need for personalized treatment
strategies. As healthcare systems around the world face the growing challenge
of multidrug-resistant infections, the demand for rapid and accurate
susceptibility testing is rising. This shift is further supported by the
adoption of advanced diagnostic technologies, such as automated systems and
point-of-care testing, which offer faster results and more precise treatment
options. The increasing investment in research and development for novel
antimicrobial agents and diagnostic tools is also boosting the market growth.
These advancements are helping clinicians make informed decisions, thereby
improving patient outcomes and reducing the unnecessary use of antibiotics.,”
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Antimicrobial
Susceptibility Testing Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, Segmented By Product (Manual Tests {MIC Strips,
Susceptibility Testing Disks, Susceptibility Plates}, Automated Instruments,
Consumables & Media), By Technique (Automated AST, Etest Method, Dilution,
Disk Diffusion, Others), By Application (Drug Development, Susceptibility
Testing, Others), By End User (Hospitals, Diagnostic Laboratories,
Biotechnology & Pharmaceutical Companies, Others), By Region and
Competition, 2020-2030F”, has evaluated the future growth potential of Global
Antimicrobial Susceptibility Testing Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Antimicrobial Susceptibility Testing Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com